(Hypertension. 1997;29:137.)
© 1997 American Heart Association, Inc.
Research Articles (Issue 1, Part 1) |
Region-Specific Neuropeptide Y Overflows at Rest and During Sympathetic Activation in Humans
the School of Biological and Chemical Sciences, Deakin University, Geelong (M.J.M.), and Baker Medical Research Institute, Melbourne, Victoria, Australia.
Correspondence to Dr Margaret Morris, Department of Pharmacology, University of Melbourne, Parkville 3052, Australia. E-mail margaret_morris@muwayf.unimelb.edu.au.
Neuropeptide Y coexists with norepinephrine in sympathetic nerves and is coreleased into the circulation on sympathetic activation. Little is known about the regional release of neuropeptide Y in humans under normal conditions or in pathophysiological situations of sympathetic activation or denervation. We measured plasma neuropeptide Y–like immunoreactivity and norepinephrine concentrations in samples taken from the brachial artery; coronary sinus; and internal jugular, antecubital, or hepatic veins in volunteers aged 20 to 64 years. Regional neuropeptide Y overflow at rest was calculated from venoarterial plasma concentration differences and plasma flow, and norepinephrine spillover was determined by [3H]norepinephrine infusion techniques. Cardiac release of neuropeptide Y and norepinephrine was examined in response to various stressors as well as in clinical models of sympathetic activation, cardiac failure, and denervation after cardiac transplantation. In healthy volunteers, cardiac, forearm, and jugular venous sample neuropeptide Y concentrations were similar to arterial levels. Hepatic vein plasma neuropeptide Y was greater than arterial both at rest (119±5% of arterial, n=7) and after a meal (132±12%, n=7), with neuropeptide Y overflows of 6±2 and 11±2 pmol/min, respectively. In contrast, hepatomesenteric norepinephrine spillover was not significantly increased by feeding. Although coronary sinus plasma norepinephrine concentrations increased significantly with the cardiac sympathetic activation accompanying mental arithmetic, coffee drinking, isotonic exercise, and bicycle exercise, only the latter powerful sympathetic stimulus increased neuropeptide Y overflow. Cardiac failure was associated with increased resting release of both norepinephrine and neuropeptide Y from the heart, whereas postcardiac transplant norepinephrine spillover from the heart was reduced. The net overflow of neuropeptide Y to plasma observed at rest across the hepatic circulation, but not the cardiac, forearm, or cerebral circulations, indicates that the gut, the liver, or both make a major contribution to systemic plasma neuropeptide Y levels in humans. Sympathetic activation by exercise produced a modest increase in cardiac neuropeptide Y overflow but to only approximately 25% of the resting input from the gut and without a change in arterial neuropeptide Y concentration. Plasma neuropeptide Y measurements are less sensitive than those of plasma norepinephrine concentrations as an index for quantifying sympathetic neural responses regulating the systemic circulation.
Key Words: exercise • heart • neuropeptide Y • norepinephrine
This article has been cited by other articles:
 |
|
 |
|
  M. Nishizawa, M. Shiota, M. C. Moore, S. M. Gustavson, D. W. Neal, and A. D. Cherrington Intraportal administration of neuropeptide Y and hepatic glucose metabolism Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1197 - R1204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Chen, M. J. Hansen, J. E. Jones, R. Vlahos, G. P. Anderson, and M. J. Morris Detrimental metabolic effects of combining long-term cigarette smoke exposure and high-fat diet in mice Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1564 - E1571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Bongartz, M. J. Cramer, P. A. Doevendans, J. A. Joles, and B. Braam The severe cardiorenal syndrome: 'Guyton revisited' Eur. Heart J., January 1, 2005; 26(1): 11 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Deshmukh, B. G. Phillips, T. O'Dorisio, M. J. Flanigan, and V. S. Lim Hormonal responses to fasting and refeeding in chronic renal failure patients Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E47 - E55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Eikelis, G. Lambert, G. Wiesner, D. Kaye, M. Schlaich, M. Morris, J. Hastings, F. Socratous, and M. Esler Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E744 - E752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E.G. Lomax, K. A. Sharkey, and W. R. Giles Neuropeptide Y Modulates L-Type Ca2+ Current During Heart Development Circ. Res., November 14, 2003; 93(10): 891 - 892. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zoccali, F. Mallamaci, G. Tripepi, F. A. Benedetto, S. Parlongo, S. Cutrupi, D. Iellamo, G. Bonanno, F. Rapisarda, P. Fatuzzo, et al. Prospective Study of Neuropeptide Y as an Adverse Cardiovascular Risk Factor in End-Stage Renal Disease J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2611 - 2617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Sobey Neurogenic Atherosclerosis Mediated by Neuropeptide Y: Hardening of the Evidence Arterioscler. Thromb. Vasc. Biol., July 1, 2003; 23(7): 1137 - 1139. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Gullestad, B. Jorgensen, T. Bjuro, J. Pernow, J. M. Lundberg, C.-D. Dota, C. Hall, S. Simonsen, and B. Ablad Postexercise Ischemia Is Associated With Increased Neuropeptide Y in Patients With Coronary Artery Disease Circulation, August 29, 2000; 102(9): 987 - 993. [Abstract] [Full Text] [PDF]
|
|